vimarsana.com
Home
Live Updates
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript : vimarsana.com
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2023.
Related Keywords
Japan
,
Seattle
,
Washington
,
United States
,
Wisconsin
,
Japanese
,
Americans
,
William Blair
,
America Merrill Lynch
,
Andrew Brackmann William Blair
,
Kevin Conroy
,
Dan Brennan
,
Mark Massaro
,
Megan Jones
,
Puneet Souda Leerink
,
Patrick Donnelly Citi
,
Vijay Kumar Evercore
,
Goldman Sachs
,
Matt Sykes Goldman Sachs
,
Erik Holznecht
,
Jeff Elliott
,
Dan Leonard
,
Brandon Couillard Jefferies
,
Everett Cunningham
,
Kyle Mikson Canaccord Genuity
,
European Society Of Medical Oncology Congress
,
Jack Meehan Nephron Research Analyst
,
Derik De Bruin Bank
,
Health Systems
,
Company Analyst
,
Jack Meehan At Nephron Research
,
United States Preventive Services Task
,
Dan Arias Stifel Financial Corp
,
Albert Hu Craig Hallum Capital Group Analyst
,
American College Of Gastroenterology Conference
,
Exact Sciences
,
Exact Science
,
Motley Fool Stock Advisor
,
Stock Advisor
,
Chief Executive
,
Resolution Biosciences
,
American College
,
Gastroenterology Conference
,
Precision Oncology
,
European Society
,
Medical Oncology
,
Financial Officer
,
Chief Operating
,
Catherine Schulte
,
Brandon Couillard
,
New Year
,
Derek De Bruin
,
Andrew Brackmann
,
Vijay Kumar
,
Res Bio
,
Matt Sykes
,
Patrick Donnelly
,
Jack Meehan
,
United States Preventive Services Task Force
,
Puneet Souda
,
Cologuard Blood
,
Dan Arias
,
Analyst Day
,
Kyle Mikson
,
Eve Burstein
,
Scare Gap
,
Alex Nowak
,
Hallum Capital Group
,
Chief Commercial
,
Nephron Research
,
Leerink Partners
,
Stifel Financial
,
vimarsana.com © 2020. All Rights Reserved.